What is the clinical significance of an albumin‑creatinine ratio of 87 mg/g?

Clinical Significance of Albumin-Creatinine Ratio of 87 mg/g

An albumin-creatinine ratio of 87 mg/g indicates moderately increased albuminuria (formerly called microalbuminuria), which significantly increases your risk for chronic kidney disease progression, cardiovascular disease, and all-cause mortality—you need confirmation testing, evaluation of underlying causes, and initiation of protective therapy.

Understanding Your Result

Your ACR of 87 mg/g falls into the moderately increased albuminuria category (30-299 mg/g) 1, 2, 3. This is not normal—it represents kidney damage and endothelial dysfunction that requires medical attention.

Classification Context:

• Normal: <30 mg/g
• Moderately increased (your result): 30-299 mg/g
• Severely increased: ≥300 mg/g 4, 5

Immediate Next Steps

1. Confirmation Testing Required

You must obtain 2 additional first-morning void urine samples within the next 3-6 months 1, 4. The diagnosis requires 2 of 3 samples to be elevated to confirm persistent albuminuria and avoid misclassification from temporary elevations.

Avoid these confounders before testing:

• Vigorous exercise within 24 hours
• Active urinary tract infection
• Fever or acute illness
• Marked hyperglycemia
• Uncontrolled hypertension
• Congestive heart failure 2, 4

2. Assess for Underlying Causes

Evaluate immediately for:

• Diabetes mellitus (HbA1c, fasting glucose)
• Hypertension (blood pressure measurement)
• Estimated GFR (serum creatinine with eGFR calculation) 3, 6
• Cardiovascular disease risk factors (lipid panel)

Risk Implications

Mortality and Cardiovascular Risk

Your ACR of 87 mg/g carries substantial prognostic significance:

• Increased all-cause mortality risk even within the "moderately increased" range 7, 8, 9
• 2-3 fold increased cardiovascular disease risk 2, 6
• Progressive kidney disease risk, particularly if you have diabetes or hypertension 4, 5

The relationship between ACR and adverse outcomes is continuous—there is no safe threshold once above 30 mg/g 6.

Monitoring Frequency

Based on KDIGO guidelines, with an ACR of 87 mg/g:

• If your eGFR is ≥60: Monitor every 6-12 months 6
• If your eGFR is 45-59: Monitor every 6 months 6
• If your eGFR is <45: Monitor every 3-6 months 6

Treatment Priorities

1. Blood Pressure Control

Target blood pressure <130/80 mmHg using:

• ACE inhibitors or ARBs as first-line therapy regardless of baseline blood pressure if you have diabetes 2, 4, 5
• These medications reduce albuminuria by 30-50% and slow kidney disease progression 2, 3

2. Glycemic Control (if diabetic)

Target HbA1c <7% (individualize based on comorbidities) 2, 5

• Intensive glucose control delays onset and progression of albuminuria 2

3. Treatment Goal for Albuminuria

Aim to reduce your ACR by at least 30-50%, ideally to <30 mg/g 3. This reduction serves as a surrogate marker for slowed kidney disease progression.

4. Additional Interventions

• Lipid management (statin therapy for cardiovascular risk reduction)
• Smoking cessation if applicable
• Dietary protein restriction to 0.8-1.0 g/kg/day if kidney function declining 5
• SGLT2 inhibitors if diabetic (additional kidney and cardiovascular protection) 3

Specialist Referral Criteria

Consider nephrology referral if:

• eGFR <60 mL/min/1.73 m² 2, 3
• Rapidly increasing proteinuria
• eGFR decline >30% within 2-3 months after starting ACE inhibitor/ARB 4
• Uncertainty about kidney disease etiology 4
• Difficulty managing hypertension or hyperkalemia 2

Important Caveats

Variability Considerations

ACR demonstrates high within-individual variability (coefficient of variation ~49%) 10. This means:

• A single elevated value requires confirmation
• Multiple collections improve diagnostic accuracy
• Day-to-day fluctuations are normal but don't negate the underlying risk

Sex Differences

Women have lower urinary creatinine excretion, resulting in higher ACR values for the same albumin excretion 11. However, the same diagnostic thresholds apply to both sexes in current guidelines 1.

Bottom Line

Your ACR of 87 mg/g is not benign—it represents established kidney damage with increased cardiovascular and mortality risk. Confirm with repeat testing, identify and treat underlying causes (especially diabetes and hypertension), initiate ACE inhibitor or ARB therapy, and establish regular monitoring. The goal is to reduce your ACR substantially and prevent progression to more severe kidney disease and cardiovascular events.